ATAD1 and malaria: Only a limited number of studies have reported antibody responses to multiple malarial antigenic targets, other than CSP or AMA1 and MSP1-19 alone, in the previously malaria naïve control groups of CHMI trials (Turner et al., 2011; Obiero et al., 2015; Hodgson et al., 2016).